Connect to other sites within the UBM Medica Network
We are proud to announce an expanded set of CMEs on our site - 30 credits, all free, all year!
New Treatment Guidelines for Antipsychotic Use in Dementia
When agitation and psychosis symptoms are severe, is an antipsychotic medication an option? Not always.
Sexual Dysfunction, SSRIs, and Depression
Improvement in depressive symptoms appears to have a salutary effect on sexual function.
Extracurricular Activities for Early-Career Psychiatrists
With the standard aversion to moonlighting in the emergency department at the local hospital, lots of us have asked the same question: “What else can I do to pay the bills?”
Antipsychotics in Treatment-Resistant Schizophrenia
Is clozapine still the gold standard for treatment-resistant schizophrenia?
Introduction: Working With Patients Who Have Eating Disorders
An introduction to our 2-part Special Report on eating disorders, including neurobiology of eating disorders, nutritional needs of patients, clinical response to psychosis, and more.
Neurobiology of Eating Disorders: Clinical Implications
New insights into neural pathways that play a role in anorexia nervosa, bulimia nervosa, and binge eating disorder.
Understanding Nutritional Needs of Patients With Eating Disorders: Implications for Psychiatrists
Eating disorders are second only to substance-abuse disorders in having the highest mental illness mortality rate. How do we assist the patient in moving forward?
Challenges of Treating Depression in the Elderly
Comorbid medical symptoms, polypharmacy, and cognitive decline are hallmarks of depression in the fastest growing segment of the population.
Marijuana—Legal, But Not by Prescription
What are the pros and cons of marijuana use? Dr Andrew Saxon gives his viewpoint on why he is against medical marijuana but in favor of legalization of recreational use of marijuana.
New Psychopharmacology Algorithms
Dr David Osser offers compelling reasons why you might want to take a look at these 7 algorithms, each of which offers actionable consultations—usually in under 2 minutes.
Leaders in Psychiatry: Jeffrey A. Lieberman, MD
What does Dr Lieberman have to say about the state of psychiatry today, as it relates to schizophrenia, major depression, and other psychiatric disorders? More in this video.
In This Issue: Volume 33, No. 3
Check out what's new in schizophrenia research, personality disorders, patient education, integrative psychiatry, addiction, and more.
Depression Research Update: April 2016
The studies discussed in this slideshow assess the benefits of non-traditional therapies for depressive disorders.
The World of Personality Disorders in 6 Clinical Reports
Here's what's new in personality disorders: DBT treatment, DSM-5 criteria, borderline personality disorder, narcissistic personalities, and mentalization-based treatments.
Psychiatry Roundup: March 2016
Editors' choices of noteworthy psychiatry stories from around the Web: genetics of schizophrenia, Alzheimer disease, the perils of mixing prescription and over-the-counter medications, new guidelines for treating pain with opioids, and other topics.
Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.
By clicking Accept, you agree to become a member of the UBM Medica Community.